首頁 > 市場調查報告書 > 醫療設備

導管心血管設備

市場調查報告書

商品編碼

1096521

主動脈瓣的全球市場:現狀分析與預測(2021年～2027年)

Aortic Valve Market: Current Analysis and Forecast (2021-2027)

出版日期: 2022年05月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 202 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球主動脈瓣的市場規模在預測期間(2021年～2027年)中預計將以約13％的年複合成長率成長。

心臟瓣膜症的盛行率的上升和老年人口的增加，成為促進主動脈瓣市場成長的要素之一。再加上日益嚴重的全球瓣膜病也在推動市場增長。

本報告提供全球主動脈瓣市場的相關調查，提供市場洞察，市場趨勢，競爭模式，企業概要等全面性資訊。

Global Aortic valve Market is anticipated to grow with an elevated CAGR of around 13% over the forecast period (2021-2027). The aortic valve allows blood to flow in the right direction in the heart. It separates the main pump chamber of the heart (left ventricle) from the main arteries that supply the body with oxygen-rich blood (aorta). Each time the ventricle contracts, the aortic valve opens, allowing blood to flow from the left ventricle to the aorta. When the ventricles relax, the aortic valve closes and prevents blood from flowing back into the ventricles.

The growing prevalence of heart valve disease coupled with the rising geriatric population is another factor contributing to the growth of the aortic valve market. For instance, according to the United Nations, In 2019, 13.2% of the worldwide population was aged 60 years or above. Further, it is anticipated that nearly 21.4% of the total worldwide population will be aged 60 years or over by 2050. In view of these facts, there is a rising prevalence of aortic regurgitation which creates the need for heart valve replacement which in turn is driving the aortic valve market globally.

Furthermore, The rising worldwide demand for the aortic valve is because of the increase in valvular diseases globally. For instance, as per CDC, About 2.5% of the U.S. population has valvular heart disease, but it is more common in older adults. About 13% of people born before 1943 have valvular heart disease. However, some of the restraints in the market include stringent regulatory framework and product failure and recalls are impeding the growth of this market all over the world. Boston Scientific Corporation, Edwards Lifesciences Corporation, CryoLife Inc., Medtronic plc, LivaNova PLC, Abbott Laboratories, JenaValve Technology Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Coroneo Inc, are some of the prominent players operating in the aortic valve market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with aortic valves.

Insights Presented in the Report

"Amongst Valve Type, Tissue/Biological segment holds the major share"

Based on valve type, the market is bifurcated into tissue/biological type and mechanical type. The tissue/biological type segment occupied the major share of the artificial blood vessels market in 2020 and it is expected to grow with a substan]ial CAGR in the upcoming years owing to the various advantages associated with this type of valve such as avoiding lifelong warfarin therapy to prevent the formation of blood clots, long-term durability, and free from reoperation for valve degeneration. Owing to this, many key industry players are launching new and advanced products in the market. For example, in September 2021, Abbott announced that the FDA has approved the company's Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease.

"Amongst Suture Type, Sutureless segment holds the major share"

Based on suture type, the aortic valve market is bifurcated into sutured and sutureless. The sutureless segment occupied the major share of the aortic valve market in 2020 and it is expected to grow with a substantial CAGR in the upcoming years owing to its reduced duration of cross-clamp and cardiopulmonary bypass (CPB) procedures compared to sutured valves.

"Amongst Procedure, Minimally Invasive Surgery segment holds the major share"

Based on the procedure, the market is bifurcated into open surgery and minimally invasive surgery. The minimally invasive surgery segment occupied the major share of the aortic valve market in 2020 and it is expected to grow with a substantial CAGR in the upcoming years as minimally invasive surgery causes less trauma to the patients and facilitates faster recovery than open-heart surgery as the geriatric population takes more time to get recover from surgery.

"Amongst End-Users, hospitals segment holds the major share"

Based on end-users, the market is fragmented into hospitals, and ambulatory surgical centers. In 2020, hospitals segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the increasing construction of hospitals and a surge in the number of heart surgeries in the hospital setting. However, ambulatory surgical centers are also likely to witness the fastest growth during the forecast period.

"Europe represents one of the largest markets of aortic valve market"

For a better understanding of the market dynamics of the aortic valve market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. Europe constitutes a major market for the aortic valve market industry and generated revenue of USD XX Million in 2020 owing to strong healthcare infrastructure and growing adoption of the aortic valve in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

The global aortic valve market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Limitation
1.3. Stakeholders
1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Aortic Valve Market
2.2. Research Methodology of the Aortic Valve Market
2.3. Forecasting Method
2.4. Respondent Profile
2.5. Main Objective of the Aortic Valve Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 AORTIC VALVE MARKET COVID-19 IMPACT

6 AORTIC VALVE MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY VALVE TYPE

7.1. Tissue/ Biological
7.2. Mechanical

8 MARKET INSIGHTS BY SUTURE TYPE

8.1. Sutured
8.2. Sutureless

9 MARKET INSIGHTS BY PROCEDURE

9.1. Open Surgery
9.2. Minimally Invasive Surgery

10 MARKET INSIGHTS BY END-USERS

10.1 Hospitals
10.2 Ambulatory Surgery Centers

11 MARKET INSIGHTS BY REGION

11.1. North America
- 11.1.1 US
- 11.1.2 Canada
- 11.1.3 Rest of North America
11.2 Europe
- 11.2.1 Germany
- 11.2.2 UK
- 11.2.3 France
- 11.2.4 Italy
- 11.2.5 Spain
- 11.2.6 Rest of Europe
11.3 Asia-Pacific
- 11.3.1 China
- 11.3.2 Japan
- 11.3.3 India
- 11.3.4 Australia
- 11.3.5 Rest of Asia-Pacific
11.4 Rest of World

12 AORTIC VALVE MARKET DYNAMICS

12.1 Market Drivers
12.2 Market Challenges
12.3 Impact Analysis

13 AORTIC VALVE MARKET OPPORTUNITIES

14 AORTIC VALVE MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

16.1 Demand Side Analysis
16.2 Supply Side Analysis
- 16.2.1 Top Product Launches
- 16.2.2 Top Business Partnerships
- 16.2.3 Top Business Expansions
- 16.2.4 Top Merger and Acquisitions

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

18.1 Porter's Five forces analysis
- 18.1.1 Bargaining power of Supplier
- 18.1.2 Bargaining power of Buyer
- 18.1.3 Industry Rivalry
- 18.1.4 Availability of Substitute
- 18.1.5 Threat of new Entrants